Executive Summary Generics were proposed to decrease the cost of drugs in the US greatly. Why did this outcome not occur as predicted? Introduction One of the most widely accepted assumptions is that generic drugs reduce the cost of drugs in the US. We cover in this article why this assumption, while perfectly rational, is…
Executive Summary The FDA has a long history of covering up clinical trial fraud by pharmaceutical companies. Introduction The less one knows about the FDA, the more legitimate the agency appears, and conversely, the more one looks into the behavior of the FDA, the worse the story gets. Wait One Second… Why is The Article…
Executive Summary Falsifying bioequivalence tests for approval are done frequently — and the FDA does not do anything about false bioequivalence when pointed directly to it. Introduction The FDA promotes bioequivalence as the case with all generics, even those made in India that fail their inspections, often have their bioequivalence trials falsified. Wait One Second……
Executive Summary Side effects of chemotherapy are usually listed in an antiseptic way at the major medical sites that promote chemotherapy. The following are first-hand accounts of the side effects. Introduction The side effects of chemotherapy are horrid. And it is essential to do what oncologists and cancer centers don’t want patients to do —…
Executive Summary Falsifying bioequivalence is commonly done by what is called clinical research organizations or CROs. Introduction A significant issue with falsifying bioequivalence is the companies paid to prove rather than test bioequivalence. These are called Clinical Research Organizations or CROs. Wait One Second… Why is The Article Not Viewable? You are seeing this text…
Executive Summary Bioequivalence testing is much more complicated and fraught with limitations than generally understood. The World Health Organization and Generic Drug Production Introduction Patients are repeatedly told there is no difference between generics and brand-name drugs. How this assertion is proven tends to be left out of the conversation, and that is what we…
Executive Summary What is shared by the brand name drug manufacturers with generic manufacturers is far different than generally assumed. Introduction Something that is little known except by those working in the pharmaceutical industry with generics is the process of developing a generic from a brand-name drug. I will focus on the information shared between…
Executive Summary The idea behind the WHO’s Essential Medicines List was to promote local manufacturing, which has not occurred in smaller or larger countries. The World Health Organization and Generic Drug Production Introduction An important part of understanding generic drugs is understanding the World Health Organization’s Essential Drug List and program. The essential medicine list…
Executive Summary The pros and cons of generic drugs require precisely this type of article to explain. Introduction Generic drugs are one of the least understood medicine areas that most impact patients’ health. In this article, we will cover the pros and cons of generics. Wait One Second… Why is The Article Not Viewable? You…
Executive Summary Bioequivalence is the similarity of a generic drug to the original. Generics have a known issue with bioequivalence that is often discussed separately from the topic of Indian manufacturing. Introduction Two issues that deeply intersect but are not discussed in unison are the significant variance between generics and the original drug and how…